News

Scientists have discovered a new protein which triggers the growth of blood vessels in breast cancer tumours which have spread to the brain, a common location which breast cancer can spread to.

Transaction to extend laboratory partnership serving patients and physicians in Southern California while bolstering Quest's growth strategy in the region.

Intertek, a leading quality solutions provider to industries worldwide, is expecting the demand for its food services business to increase in the Gulf region during Ramadan.

Juniper Pharma Services has entered into a long-term collaboration with OxSonics Limited to support the development, scale-up, and GMP manufacturing of OxSonics’ proprietary “sono-sensitive particles.”

Researchers at Duke University School of Medicine and Brigham and Women’s Hospital, Harvard Medical School have identified a mechanism that explains why some mutations can be disease-causing in one genome but benign in another.

Chemists and biologists at UC San Diego have succeeded in designing and synthesizing an artificial cell membrane capable of sustaining continual growth, just like a living cell.

Celgene and Juno Therapeutics have launched a 10-year global collaboration to develop and commercialize cancer and autoimmune diseases immunotherapies.

US patent for medical use in cancer and Canadian composition of matter patent granted.

An ‘exhausted’ army of immune cells may not be able to fight off infection, but if its soldiers fight too hard they risk damaging the very body they are meant to be protecting, suggests new research from the University of Cambridge.

Artel to host September meeting of global experts in Maine.